摘要
目的:筛选高致病禽流感病毒核蛋白(NP)中可用于高致病禽流感病毒感染检测或疫苗设计的CTL表位,为评价疫苗接种效果和开发新型疫苗奠定基础。方法:根据NCBI公布的NP的核苷酸序列设计特异性引物,以2006年深圳株高致病禽流感H5N1病人分离的病毒cDNA为模板扩增NP全长基因(1500 bp)并测序。通过生物信息学方法,预测NP氨基酸序列中潜在的HLA-A觹0201限制性表位。构建重组pJW4303-NP核酸疫苗并肌肉免疫HLA-A2/DP4转基因小鼠,利用ELISPOT法筛选特异性CTL表位。结果:克隆了2006年深圳株高致病禽流感NP基因,构建的重组pJW4303-NP核酸疫苗能在体外COS-7细胞中表达,免疫小鼠后能引起小鼠产生特异性的体液免疫和细胞免疫。结论:生物信息学和转基因小鼠模型筛选相结合的方法,能用于高致病性禽流感核蛋白CTL表位的筛选。
Objective: To identify CTL epitopes in nucleoprotein(NP) of H5N1 influenza virus.Methods: The cDNA of H5N1 influenza virus(A / Shenzhen / 406H / 06) and specific primers were used to amplify the NP gene.Af-ter sequencing,NP gene was subcloned into vector pJW4303 for immunization.We screened NP protein by bioin-formatics to predict potential HLA-A2 restricted epitopes and synthesized 10 top score epitopes.Subsequently,HLA humanized mice were immunized by pJW4303-NP plasmid and ELISPOT assay was used to observe specific CTL response.Results: pJW4303-NP recombinant plasmid was successfully constructed.After DNA immunization,signif-icant humoral and cellular responses could be detected in HLA transgenic mice.Conclusion: The method that combined bioinformatics and HLA transgenic mice can be applied to identify the CTL epitopes of H5N1.
出处
《生物技术通讯》
CAS
2011年第5期657-661,共5页
Letters in Biotechnology
基金
国家"十一五"传染病重大专项动物模型课题(2009ZX1004-401)